WAKAMOTO PHARMACEUTICAL CO.,LTD. (4512) Cash flow
Market cap
¥11.8B
P/E ratio
51.4x
Wakamoto Pharmaceutical manufactures branded drugs, generic medicines, and health products like Koryoku Wakamoto for healthcare providers and consumers in Japan and internationally.
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Depreciation & amortization | 767 | 746 | 659 | 527 | 468 | 465 | 484 | 470 | 446 | 412 | 430 | 443 |
| Cash from operations | 1,175 | 594 | 1,098 | 556 | -114 | -155 | 163 | 339 | 632 | -107 | -592 | -487 |
| Capital expenditures | -1,209 | -414 | -335 | -320 | -371 | -138 | -359 | -238 | -85 | -331 | -450 | -565 |
| Cash from investing | -1,270 | -329 | 22 | -47 | -205 | -179 | -200 | 51 | 17 | -2 | -13 | -658 |
| Payments for dividends | -104 | -104 | -104 | -104 | -104 | -1 | -1 | -0 | -0 | -104 | -103 | -104 |
| Repurchases of common stock | -6 | -3 | -3 | -4 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Proceeds from issuance of term debt, net | 800 | - | - | - | - | - | - | - | - | - | - | 300 |
| Repayments of term debt | -1,006 | -208 | -328 | -160 | -160 | -40 | - | - | - | - | - | - |
| Cash from financing | -314 | -316 | -437 | -271 | -267 | -44 | -4 | -2 | -2 | -105 | -104 | 196 |